Education
About Us
Working with TipRanks
Follow Us
Jean Jacques Bienaime Insider Profile
4 Followers
Jean Jacques Bienaime, Director at BioMarin Pharmaceutical, holds 20.84K shares in Incyte (Ticker: INCY), holds 5.45K shares in Keros Therapeutics (Ticker: KROS), holds 36.41K shares in Immunome (Ticker: IMNM).
Jean Jacques Bienaime BioMarin Pharmaceutical (BMRN)Director
BioMarin Pharmaceutical (BMRN)
Director
Ranked #22,998 out of 103,225 Corporate Insiders
Profitable Transactions
20 out of 47 Profitable Transactions
Average Return
+2.30%
Average return per transaction
Time Frame
Compare to
Insider Holdings
A breakdown of Jean Jacques Bienaime's holdings
Insider Roles
Roles that Jean Jacques Bienaime holds in companies
Most Profitable Insider Trade
The most profitable trade made by Jean Jacques Bienaime
Jean Jacques Bienaime's Trading History
BioMarin Pharmaceutical
May 21, 2024
Director
Uninformative Sell
92.61K
$42.31M
Immunome
Jun 03, 2025
Director
Informative Buy
46.90K
$362.33K
Keros Therapeutics
Jun 06, 2025
Director
Uninformative Buy
―
$84.58K
Immunic
Sep 24, 2018
Director
Informative Sell
7.99K
$15.80K
Incyte
Jun 12, 2025
Director
Uninformative Buy
―
$1.77M
Portola Pharma
May 16, 2014
―
Informative Sell
22.03K
$12.73K
Neurogesx
Jul 26, 2011
―
Uninformative Buy
19.18K
$108.74
InterMune
―
―
―
―
List of latest transactions for each holding click on a transaction to see Jean Jacques Bienaime's performance on stock
You May Also Like
Jean Jacques Bienaime insider profile FAQ
What is the percentage of profitable transactions made by Jean Jacques Bienaime?
The percentage of profitable transactions made by Jean Jacques Bienaime is 43%.
What is the average return per transaction made by Jean Jacques Bienaime?
The average return per transaction made by Jean Jacques Bienaime is 2.30%.
What stocks does Jean Jacques Bienaime hold?
Jean Jacques Bienaime holds: BMRN, IMNM, KROS, IMUX, INCY, PTLA, NGSX, ITMN stocks.
What was Jean Jacques Bienaime’s latest transaction?
Jean Jacques Bienaime latest transaction was an Uninformative Buy of ―.
What was Jean Jacques Bienaime's most profitable transaction?
Jean Jacques Bienaime’s most profitable transaction was an Informative Buy of IMUX stock on April 23, 2014. The return on the trade was 138.20%.
What is Jean Jacques Bienaime's role in BioMarin Pharmaceutical?
Jean Jacques Bienaime's role in BioMarin Pharmaceutical is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.